Passage BIO, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q1 2020 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Passage BIO, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q1 2020 to Q3 2024.
  • Passage BIO, Inc. Entity Common Stock, Shares Outstanding for the quarter ending November 8, 2024 was 61.8M shares, a 12.7% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 61.8M +6.95M +12.7% Nov 8, 2024 10-Q 2024-11-13
Q2 2024 61.8M +6.96M +12.7% Aug 5, 2024 10-Q 2024-08-08
Q1 2024 55.6M +981K +1.8% Feb 28, 2024 10-K 2024-03-04
Q3 2023 54.8M +266K +0.49% Nov 8, 2023 10-Q 2023-11-13
Q2 2023 54.8M +348K +0.64% Aug 2, 2023 10-Q 2023-08-07
Q1 2023 54.6M +325K +0.6% Mar 2, 2023 10-K 2023-03-06
Q3 2022 54.6M +446K +0.83% Nov 4, 2022 10-Q 2022-11-10
Q2 2022 54.5M +370K +0.68% Aug 1, 2022 10-Q 2022-08-04
Q1 2022 54.3M +461K +0.86% Mar 1, 2022 10-K 2022-03-03
Q3 2021 54.1M +8.57M +18.8% Nov 1, 2021 10-Q 2021-11-04
Q2 2021 54.1M +8.61M +18.9% Aug 3, 2021 10-Q 2021-08-05
Q1 2021 53.8M +8.48M +18.7% Mar 1, 2021 10-K 2021-03-03
Q3 2020 45.5M Nov 10, 2020 10-Q 2020-11-10
Q2 2020 45.5M Aug 11, 2020 10-Q 2020-08-13
Q1 2020 45.4M May 8, 2020 10-Q 2020-05-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.